lerolero (@lerolerom) 's Twitter Profile
lerolero

@lerolerom

Not trying to change the world one tweet at the time. Like sports and technology.I love to be a husband and father. latest passion cryptocurrencies.

ID: 33811627

linkhttp://mepartelacabeza.blogspot.com/ calendar_today21-04-2009 04:29:14

2,2K Tweet

256 Followers

612 Following

ADHD Jesse (@adhdjesse) 's Twitter Profile Photo

ADHD is having every childhood authority figure tell you you’re gifted and have such potential, but you’re wasting it by being too lazy, spacey, selfish, or failing to β€œapply” yourself.

Benny Johnson (@bennyjohnson) 's Twitter Profile Photo

Ban all porn on X X is the town square No one wants pornography broadcast in the town square Please share if you want to ban porn on X

Christina Buttons (@buttonslives) 's Twitter Profile Photo

NEW STUDY: Antidepressants are associated with faster rates of cognitive decline in dementia patients. SSRI users also had a greater risk of fractures and all-cause mortality than non-users.

NEW STUDY: Antidepressants are associated with faster rates of cognitive decline in dementia patients. SSRI users also had a greater risk of fractures and all-cause mortality than non-users.
Paul F. Austin (@paulaustin3w) 's Twitter Profile Photo

Czech Republic just became Europe’s first nation to legalize psilocybin for medical use, covering both the natural mushroom & synthetic alkaloid. Implementation kicks off in 2026, with rollout constrained to licensed healthcare facilities under doctor supervision. Massive!

Paul F. Austin (@paulaustin3w) 's Twitter Profile Photo

In 2023, 8 million people took psilocybin mushrooms. 47% microdosed. That’s not just a trend, it’s a paradigm shift. People are ditching shitty drugs and reclaiming their minds. Microdosing is rising & SSRIs are declining. The future of mental health is already here.

Psychedelic Alpha (@psyched_alpha) 's Twitter Profile Photo

BREAKING: German regulators have green-lit the EU's first psilocybin compassionate access program. Unlike other countries’ pre-approval pathways, Germany’s does not require case-by-case regulatory approval and may see insurers cover costs. Details: psychedelicalpha.com/news/germany-e…

Eduard Sebastian (@eduard_seb) 's Twitter Profile Photo

PSILOCYBIN: The most controversial medicine in the world. It can unlock your inner healerβ€”or break your psyche open. Here’s the science behind its risks, rewards, and rise🧡:

Psychedelics.com (@psychedelicscom) 's Twitter Profile Photo

Big news: The DEA has finally advanced a petition to reschedule psilocybin after years of legal battles. 🧡 Here’s why it matters...

Big news: The DEA has finally advanced a petition to reschedule psilocybin after years of legal battles.

🧡 Here’s why it matters...
Robin Carhart-Harris (@rcarhartharris) 's Twitter Profile Photo

In the future, even more than now, what we call spiritual and mystical will: 1) still be called spiritual or mystical and 2) also be called physics.

In the future, even more than now, what we call spiritual and mystical will: 1) still be called spiritual or mystical and 2) also be called physics.
Paul F. Austin (@paulaustin3w) 's Twitter Profile Photo

If synthetic psilocybin (aka COMP360) is approved for TRD by the end of 2026, most headlines will focus on clinics, psychiatrists, and stock prices. But this misses the most critical element, IMO. Approval wouldn’t just validate synthetic psilocybin as a treatment but, more

Paul F. Austin (@paulaustin3w) 's Twitter Profile Photo

If psilocybin is dangerous, why is it less addictive than caffeine, less toxic than alcohol, and more effective than SSRIs? What do you think?

🧬Maxpein🧬 (@maximumpain333) 's Twitter Profile Photo

In 1962, a Harvard student gave theology students psychedelic mushrooms in a chapel. His paper, β€œDrugs and Mysticism,” published in the International Journal of Parapsychology, laid out what would become one of the most discussed and debated studies in the history of psychedelic

In 1962, a Harvard student gave theology students psychedelic mushrooms in a chapel.

His paper, β€œDrugs and Mysticism,” published in the International Journal of Parapsychology, laid out what would become one of the most discussed and debated studies in the history of psychedelic